The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...

Inc. revealed that its LifeGel Absorbable Hemostatic Gel received the 2024/2025 Best Technology in Spine Award for its innovations in biopolymer-based hemostatic technology for surgical control of ...

including the introduction of combination hemostats and bioactive agents, are improving surgical outcomes and reducing procedural complications. Additionally, the shift towards minimally invasive ...